Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

Similar articles for PubMed (Select 17893254)

1.

Health-related quality of life in acromegalic subjects: data from AcroBel, the Belgian registry on acromegaly.

T'Sjoen G, Bex M, Maiter D, Velkeniers B, Abs R.

Eur J Endocrinol. 2007 Oct;157(4):411-7.

2.

Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study.

Webb SM, Badia X, Surinach NL; Spanish AcroQol Study Group.

Eur J Endocrinol. 2006 Aug;155(2):269-77.

3.

Treatment of acromegaly improves quality of life, measured by AcroQol.

Paisley AN, Rowles SV, Roberts ME, Webb SM, Badia X, Prieto L, Shalet SM, Trainer PJ.

Clin Endocrinol (Oxf). 2007 Sep;67(3):358-62. Epub 2007 Jun 6.

PMID:
17555502
4.

Impaired quality of life of patients with acromegaly: control of GH/IGF-I excess improves psychological subscale appearance.

Matta MP, Couture E, Cazals L, Vezzosi D, Bennet A, Caron P.

Eur J Endocrinol. 2008 Mar;158(3):305-10. doi: 10.1530/EJE-07-0697.

5.

Assessment of quality of life in patients with uncontrolled vs. controlled acromegaly using the Acromegaly Quality of Life Questionnaire (AcroQoL).

Trepp R, Everts R, Stettler C, Fischli S, Allemann S, Webb SM, Christ ER.

Clin Endocrinol (Oxf). 2005 Jul;63(1):103-10. Erratum in: Clin Endocrinol (Oxf). 2005 Aug;63(2):238.

PMID:
15963069
6.

Quality of life (QOL) in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaire.

Rowles SV, Prieto L, Badia X, Shalet SM, Webb SM, Trainer PJ.

J Clin Endocrinol Metab. 2005 Jun;90(6):3337-41. Epub 2005 Mar 8.

PMID:
15755865
7.
8.

AcroBel--the Belgian registry on acromegaly: a survey of the 'real-life' outcome in 418 acromegalic subjects.

Bex M, Abs R, T'Sjoen G, Mockel J, Velkeniers B, Muermans K, Maiter D.

Eur J Endocrinol. 2007 Oct;157(4):399-409.

9.

Acromegaly Quality of Life Questionnaire (ACROQOL) a new health-related quality of life questionnaire for patients with acromegaly: development and psychometric properties.

Webb SM, Prieto L, Badia X, Albareda M, Catalá M, Gaztambide S, Lucas T, Páramo C, Picó A, Lucas A, Halperin I, Obiols G, Astorga R.

Clin Endocrinol (Oxf). 2002 Aug;57(2):251-8.

PMID:
12153605
10.

Previous radiotherapy negatively influences quality of life during 4 years of follow-up in patients cured from acromegaly.

van der Klaauw AA, Biermasz NR, Hoftijzer HC, Pereira AM, Romijn JA.

Clin Endocrinol (Oxf). 2008 Jul;69(1):123-8. doi: 10.1111/j.1365-2265.2007.03169.x. Epub 2008 Jul 1.

PMID:
18182092
11.

Short- and long-term changes of quality of life in patients with acromegaly: results from a prospective study.

Sardella C, Lombardi M, Rossi G, Cosci C, Brogioni S, Scattina I, Webb SM, Gasperi M, Martino E, Bogazzi F.

J Endocrinol Invest. 2010 Jan;33(1):20-5.

PMID:
20203538
12.

The 'bio-assay' quality of life might be a better marker of disease activity in acromegalic patients than serum total IGF-I concentrations.

Bonapart IE, van Domburg R, ten Have SM, de Herder WW, Erdman RA, Janssen JA, van der Lely AJ.

Eur J Endocrinol. 2005 Feb;152(2):217-24.

13.

Clinical osteoarthritis predicts physical and psychological QoL in acromegaly patients.

Wassenaar MJ, Biermasz NR, Kloppenburg M, van der Klaauw AA, Tiemensma J, Smit JW, Pereira AM, Roelfsema F, Kroon HM, Romijn JA.

Growth Horm IGF Res. 2010 Jun;20(3):226-33. doi: 10.1016/j.ghir.2010.02.003. Epub 2010 Mar 2.

PMID:
20194043
14.

Quality of life in acromegaly.

Webb SM.

Neuroendocrinology. 2006;83(3-4):224-9. Epub 2006 Oct 13. Review.

PMID:
17047387
15.

Acromegaly Quality of Life Questionnaire (AcroQoL).

Badia X, Webb SM, Prieto L, Lara N.

Health Qual Life Outcomes. 2004 Feb 27;2:13.

16.

Biochemical and quality of life responses to octreotide-LAR in acromegaly.

Mangupli R, Camperos P, Webb SM.

Pituitary. 2014 Dec;17(6):495-9. doi: 10.1007/s11102-013-0533-x.

PMID:
24178448
17.

Quality of life in female patients with acromegaly.

Celik O, Kadioglu P.

J Endocrinol Invest. 2013 Jun;36(6):412-6. doi: 10.3275/8761. Epub 2012 Nov 26.

PMID:
23211278
18.

Quality of life in acromegalic patients during long-term somatostatin analog treatment with and without pegvisomant.

Neggers SJ, van Aken MO, de Herder WW, Feelders RA, Janssen JA, Badia X, Webb SM, van der Lely AJ.

J Clin Endocrinol Metab. 2008 Oct;93(10):3853-9. doi: 10.1210/jc.2008-0669. Epub 2008 Jul 22.

PMID:
18647806
19.

Affected illness perceptions and the association with impaired quality of life in patients with long-term remission of acromegaly.

Tiemensma J, Kaptein AA, Pereira AM, Smit JW, Romijn JA, Biermasz NR.

J Clin Endocrinol Metab. 2011 Nov;96(11):3550-8. doi: 10.1210/jc.2011-1645. Epub 2011 Sep 14.

PMID:
21917873
20.

Disease-specific impairments in quality of life during long-term follow-up of patients with different pituitary adenomas.

van der Klaauw AA, Kars M, Biermasz NR, Roelfsema F, Dekkers OM, Corssmit EP, van Aken MO, Havekes B, Pereira AM, Pijl H, Smit JW, Romijn JA.

Clin Endocrinol (Oxf). 2008 Nov;69(5):775-84. doi: 10.1111/j.1365-2265.2008.03288.x. Epub 2008 Apr 29.

PMID:
18462264
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk